Matthew Roden's Net Worth
$0
Who is Matthew Roden?
Matthew Roden does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include iTeos Therapeutics, Inc., and TURMERIC ACQUISITION CORP..
SEC CIK
Matthew Roden's CIK is 0001828130
Past Insider Trading and Trends
2020 was Matthew Roden's most active year for acquiring shares with 1 total transactions. Matthew Roden's most active month to acquire stocks was the month of May. 2020 saw Matthew Roden paying a total of $0.00 for 33,217 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $10.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TURMERIC ACQUISITION CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||